“Age Reversal Is Coming.” Inside The First Human Trials - Dr David Sinclair - #1141
Aug 24, 2026 · 2h 5m
Summary
Hosts revisit their 2019 meeting to discuss David Sinclair’s breakthroughs in reversing aging using Yamanaka factors, now entering human trials for blindness. Sinclair explains the epigenetic theory of aging and reveals a new oral pill that rejuvenates mice. He also advises on longevity practices, including fasting, calorie restriction, and balancing protein intake to activate survival mechanisms.
Topics discussed
Introduction and first podcast recording in 2019
Reversing aging in mice and the Nature cover story
Why the eye was chosen for safety testing
Treating blindness and nerve damage in animals
The epigenome and the information theory of aging
How DNA compaction controls cell identity
The need to address aging early in life
Investment in longevity and expansion to other tissues
The mystery of the backup software copy
No upper limit to human life span
The breakthrough in reversing cellular aging
Secret beliefs of longevity experts and lab progress
Personal mission and being an outsider in science
Sponsor segment for G1 drink
Lifestyle pillars: diet, movement, and drugs
Critique of three meals a day and marketing
Personal hedonism and the challenge of fasting
Scientific approach to long-term fasting
Ketones and brain function during fasting
GLP-1s, gut motility, and microbiome effects
SIRT1, NAD, and the microbiome during fasting
Overcoming hunger and the cheat code for fasting
Sponsor segment for Timeline blood testing
The monkey study and caloric restriction debate
Adversity mode and SIRT1 activation
Time-restricted feeding vs. continuous eating
Branched-chain amino acids and lifespan
mTOR, protein intake, and cell growth
Sex as part of a longevity routine
Low-intensity movement and standing desks
Sleep hygiene and relaxation practices
Common sleep mistakes and wearable data
Managing daily stress and visualization
Self-reliance and resilience in aging
Sponsor segment for Function Health
Resveratrol research and recent publications
The resveratrol controversy and Pfizer's claim
Scientific redemption and media reporting
NAD levels and the debate on aging
FDA regulations and clinical trials
Daily aspirin use and dosage
Alpha lipoic acid and supplement stack
Genetic predisposition to high cholesterol
Low-carb diet experience and cholesterol spike
Arterial plaque detection and diet change
Nattokinase and carotid ultrasound monitoring
Blood flow and its role in disease prevention
Blood flow, hair loss, and sexual health
Omega-3 supplementation and inflammation
NMN supplement quality and endotoxin issues
Verifying supplement purity and analytics
Launching a longevity community and newsletter
Monthly science newsletter and epigenetic clocks
Hearing science directly from researchers
Individual knowledge vs. physician expertise
Brown fat and cold exposure benefits
Building brown fat through cold exposure
Views on Andrew Huberman and longevity media
Assessing new longevity trends and data
Wastes of money: vitamin overdosing
B12 injection risks and confusion
Red light therapy and infrared panels
GLP-1 drugs and mechanisms beyond calorie restriction
Obesity vs. malnutrition and GLP-1 usage stats
Framing self-identity and discipline
The snowball effect of healthy habits
Future perspectives on current health advice
New student and the search for backup software
AI's role in revolutionizing biology
In silico experiments and virtual labs
AI-generated molecules for aging reversal
The role of expectation and optimism in longevity
Redefining old age with a healthy father
Personal health improvements and plant-based diet
Light exposure and circadian rhythm
Psychotherapy and talking about problems
Mouth taping and testosterone therapy
Treating health as a hobby and experiment
Sponsor segment for Uber Eats
Listen ad-free on Castria